AKT1 and neoplasm: By attaching to a specific binding site on PTEN 3′UTR luciferase reporter, miR-718 decreased PTEN’s tumor suppressor activity in a dose-dependent manner, thus activating the AKT/mTOR signaling pathway and therefore promoting cell proliferation and angiogenesis (Xue et al., 2014).